This article has been updated from a previous version, which incorrectly stated that SciClone Pharmaceuticals is a customer of the Hamamatsu FDSS 6000.

PHILADELPHIA — Japanese photonics component and instrumentation maker Hamamatsu is "making progress" in its attempt to gain US and European market penetration for its Functional Drug Screening System 6000, a high-throughput plate reader for multiple cell-based assay applications, a company official told CBA News at the World Pharmaceutical Congress held here last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.